Ca2+ modulates the inhibition of (+)-[3H]isradipine binding by amiloride and quinacrine
- 1 December 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 227 (4) , 379-384
- https://doi.org/10.1016/0922-4106(92)90154-n
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interactions of calmodulin antagonists with calcium antagonists binding sitesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from controlJournal of Molecular and Cellular Cardiology, 1991
- Methods for analyzing and interpreting cooperativity in dose-response curves—I. Antagonist effects on angiotensin receptors in smooth muscleGeneral Pharmacology: The Vascular System, 1989
- Amiloride: Effects on myocardial force of contraction, sodium pump and Na+/Ca2+ exchangeJournal of Molecular and Cellular Cardiology, 1986
- High affinity specific [3H] (+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heartLife Sciences, 1984
- Molecular Pharmacology of the Calcium ChannelJournal of Cardiovascular Pharmacology, 1984
- Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypesLife Sciences, 1981
- Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium propertiesLife Sciences, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949